What Researchers Did
The authors discussed whether hyperbaric oxygen therapy (HBOT) could be tested for diabetic kidney disease, and they reported urine test results from patients who had 6 weeks of HBOT for diabetic foot ulcers.
What They Found
This was a discussion paper with a preliminary prospective clinical report, and the authors state that the preliminary urine data support the concept that HBOT can reduce markers of kidney injury, oxidant stress and mitochondrial dysfunction in patients receiving HBOT for diabetic foot ulcers. The patients had urinary metabolomic data collected before and after 6 weeks of HBOT. The abstract gives no sample size, pressure, session count or statistics. The authors say further studies are needed to confirm these first findings and to link them with simultaneous measures of kidney function.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The clinical data are preliminary, come from patients treated for foot ulcers rather than kidney disease, and were not matched with measures of kidney function, so the results cannot show that HBOT protects the kidneys.